检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Priya Pate Bhumi Ladani Gayatri Patel
出 处:《Medicine in Novel Technology and Devices》2024年第1期71-79,共9页医学中新技术与新装备(英文)
摘 要:The purpose of the current investigation was to develop a pharmaceutical equivalent osmotic drug delivery formulation of Paliperidone(PLD)in the form of controlled porosity osmotic pump tablets(CPOT)in order to keep the drug's steady state concentration in the body.This helps to achieve the greatest therapeutic benefit with the fewest side effects.For the purpose of identifying various formulation attributes,preliminary trials were conducted.Taguchi design was used to study the influence of seven input factors namely drug to polymer ratio,polymer 1(HPMC K100 M)to polymer 2(HPMC K15M),drug to total osmogens,coating level,amount of pore former,concentration of ethyl cellulose and amount of plasticizer on dependent variable similarity factor(f2).Utilizing the Minitab 17,data analysis was done.The similarity factor(f2)was computed using the osmotic tablet reference product INVEGA®.The findings demonstrate that each of the seven independent variables significantly affects the similarity factor.For optimized batch,both core and coated tablets showed acceptable pharmaco-technical parameters.The release profile of the optimized batch tablets was found to be similar to that of reference product with good zero-order release pattern.Drug release was observed through the channels formed by in-situ pores on tablet surface performed using SEM.From the results it can be concluded that prepared CPOT of PLD was found pharmaceutical equivalent with commercial product which is cost effective and fully compliance with cGMP.
关 键 词:Controlled release pH-independent release Similarity factor Pharmaceutical equivalent Reference product
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117